Our previous HD-CARE president, Dr. Sarah Hernandez, is featured on an HDBuzz Research Update. Watch today! https://www.youtube.com/watch?v=iEmA8FkM010
Charles Sabine Tedx BATH Talk
Charles Sabine is part of our HD community and delivered an outstanding Tedx Talk on his experience with Huntington's disease. Check out: The Unlimited Capability of Every Human | Charles…
Youthful competitors: young brain cells oust the old
A recent publication that has garnered a lot of press looked at the effects of replacing cells in the brains of mice that model HD - with surprising findings. The…
Join us for Sounds of the Bayou!
Register today! HD-Care invites you to our summer fundraiser on Saturday September 30, 2023 1-4pm at Campus Jax. Live music and "Live Ask" opportunity to support HD research and patient…
Thanks to UCI MIND for highlighting our 10 years of hard work!
In the UCI MIND quarterly newsletter, HD-CARE is celebrated as 10 years as a non-profit organization! Check out the article along with other exciting news from UCI: https://mind.uci.edu/mind-matters-quarterly-newsletter-winter-2023/
Celebrating 30 years since the discovery of the HD mutant gene!
30 years ago, the Huntington's Disease Collaborative Research Group identified the Huntington's disease (HD) mutant gene. By examining 75 disease families, they found a trinucleotide (CAG) repeat that is expanded…
How Huntington’s Disease Affects Different Neurons
Brand new publication of 2023 highlighting how different types of neurons are affected in Huntington’s disease in Neuroscience News. Paper was originally published in Nature Communications from the labs of Dr. Manolis Kellis, Dr. Myriam Heiman and Dr. Ann Graybiel.
HD-CARE Symposium 2022
After a two year break due to COVID, HD-CARE again held its annual symposium at the Sue and Bill Gross Stem Cell Research Center on October 29. In a change…
Prolonged Grief Disorder, A Novel Diagnosis
Contributors: Ken Kast and Frances Saldaña HD-CARE Board Members Prolonged Grief is a novel diagnosis. It was officially included in the 2021 update to The Diagnostic and Statistical Manual of Mental Disorders,…
Roche/Genentech plans for GENERATION HD2, a new Phase II clinical study
Roche and Genentech announce new clinical trial to begin early next year - Generation HD2 - to explore the use of tominersen in younger, less symptomatic HD patients. Click here…